Janney Montgomery Scott LLC Raises Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Janney Montgomery Scott LLC raised its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 63.0% during the third quarter, Holdings Channel.com reports. The firm owned 106,727 shares of the health services provider’s stock after purchasing an additional 41,250 shares during the period. Janney Montgomery Scott LLC’s holdings in Teladoc Health were worth $980,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Signaturefd LLC increased its position in shares of Teladoc Health by 148.7% during the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after purchasing an additional 1,715 shares during the last quarter. International Assets Investment Management LLC purchased a new position in Teladoc Health during the second quarter worth about $29,000. Blue Trust Inc. increased its position in shares of Teladoc Health by 84.5% during the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after acquiring an additional 1,854 shares during the last quarter. Doheny Asset Management CA purchased a new stake in shares of Teladoc Health in the 2nd quarter valued at approximately $46,000. Finally, SageView Advisory Group LLC acquired a new position in shares of Teladoc Health in the 1st quarter worth approximately $48,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Stock Up 2.8 %

Shares of Teladoc Health stock opened at $9.21 on Friday. Teladoc Health, Inc. has a 52-week low of $6.76 and a 52-week high of $22.54. The company has a 50 day moving average of $8.89 and a 200 day moving average of $9.39. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $1.59 billion, a P/E ratio of -1.60 and a beta of 0.90.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.10. The business had revenue of $640.51 million during the quarter, compared to analysts’ expectations of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, research analysts forecast that Teladoc Health, Inc. will post -1.19 EPS for the current fiscal year.

Insiders Place Their Bets

In other Teladoc Health news, CFO Mala Murthy sold 8,750 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $62,650.00. Following the sale, the chief financial officer now owns 85,767 shares of the company’s stock, valued at approximately $614,091.72. This trade represents a 9.26 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Thomas Mckinley bought 4,000 shares of the stock in a transaction dated Thursday, September 12th. The stock was bought at an average price of $7.69 per share, with a total value of $30,760.00. Following the acquisition, the director now owns 39,077 shares in the company, valued at approximately $300,502.13. This represents a 11.40 % increase in their position. The disclosure for this purchase can be found here. Insiders sold 20,051 shares of company stock valued at $143,565 in the last ninety days. Insiders own 0.95% of the company’s stock.

Wall Street Analyst Weigh In

TDOC has been the subject of several research reports. Canaccord Genuity Group dropped their target price on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating for the company in a report on Thursday, August 1st. Oppenheimer dropped their price objective on Teladoc Health from $21.00 to $17.00 and set an “outperform” rating for the company in a research note on Thursday, August 1st. TD Cowen cut their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. Stifel Nicolaus lowered their target price on Teladoc Health from $16.00 to $9.00 and set a “hold” rating for the company in a report on Thursday, August 1st. Finally, Evercore ISI lifted their target price on Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Fourteen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Teladoc Health has a consensus rating of “Hold” and a consensus target price of $12.08.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.